Skip to content

Syndax Pharmaceuticals SNDX Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$243.25M+26.6%-$285.42M+10.5%-$311.58M-4.9%-$334.99M-26.8%-$331.2M-37.6%
$49.18M+10.5%$47.5M+10.4%$48.55M+24.3%$48.4M+36.6%$44.51M+32.4%
-$278.16M+2.9%-$322.98M-17.5%-$310.88M-20.1%-$302.67M-25.5%-$286.52M-39.8%
$234.28M$290.04M-$60.52M-$46.1M
$20.66M-94.1%$13.68M-96.1%$355.18M+34.3%$352M+33.8%$352.13M+33.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Syndax Pharmaceuticals generate?
Syndax Pharmaceuticals (SNDX) generated -$278.2M in operating cash flow over the trailing twelve months.
Where does Syndax Pharmaceuticals's cash flow data come from?
Every line is extracted from Syndax Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.